Your are eligible for Medicine on Earth
one year after your first
AMEDEO subscription (i.e. if you subscribed before
Sep 08, 2009 and if you have a medical profession. The Amedeo Team will inform you in time.
Direct access
YasuhiroKANEDA
Department of Psychiatry,
Iwaki Clinic
11-1 Kamimizuta, Gakubara
774-0014
Anan
Japan
email: kaneday-tsh@umin.ac.jp
Phone: +81-884-23-5600
Fax: +81-884-22-1780 Web site
Fields of Interest: Clinical neuropsychopharmacology
Curriculum Vitae
Degrees:
Ph.D. from The Univ. of Tokushima School of Medicine, Tokushima, Japan (March, 1997)
M.D. from The Univ. of Tokushima School of Medicine (March, 1992)
Medical licenses:
Japan Medical Association-certified Occupational Health Physician (January, 2007)
Japanese Society of Clinical Neuropsychopharmacology-certified specialist in Clinical Neuropsychopharmacology (January, 2006)
Japan Psychogeriatric Society-certified specialist in Geriatric Psychiatry (April, 2004)
European Certificate in Anxiety and Mood Disorders (June, 2001)
Qualified psychiatrist (April, 1998)
License of physician (May, 1992)
Career history:
2006-Current:
Councilor of Japanese Society of Clinical Neuropsychopharmacology; Medical Director at the Department of Psychiatry, Iwaki Clinic, Anan, Japan; Consultant at the Public Health Center, Anan
2004-Current:
Lecturer at the College of Welfare, Tokushima, Japan; Consultant at the Department of Neuropsychiatry, Fujii Hospital, Anan; Research Board of Advisors of the American Biographical Institute; Consultant at the Private Health Facility for senior citizens, Komatsushima, Japan
2003-Current:
Consulting Editor of The Contemporary Who's Who, American Biographical Institute
2004-2006:
Medical Director at the Dept. of Psychiatry Tokushima Univ. Hospital, Tokushima; Consultant at the Public Health Center, Tokushima
2000-2006:
Assistant Professor at the Dept. of Neuropsychiatry Univ. Hospital of Tokushima
2002-2004:
Visiting Research Fellow at the Dept. of Psychiatry, Vanderbilt Univ. School of Medicine, Nashville, USA; Councilor of Japanese Society of Psychosomatic Medicine
2000-2002:
Lecturer at the Dept. of Medical Technology School of Medical Sciences, The Univ. of Tokushima; Medical Director at the Dept. of Neuropsychiatry Univ. Hospital of Tokushima; Consultant at the Dept. of Neuropsychiatry, Fujii Hospital & Public Mental Health Center
1998-2002:
Lecturer at the College of Welfare
1996-2002:
Consultant at the Private Health Facility for senior citizens
1997-2000:
Dept. Head of the Dept. of Neuropsychiatry, Fujii Hospital
1997-1999:
Lecturer at the Dept. of Neuropsychiatry, The Univ. of Tokushima School of Medicine
1995-1997:
Consultant at the Public Mental Health Center
1993-1997:
Consultant at the Dept. of Neuropsychiatry, Fujii Hospital
1992-1993:
Internship & Residency at the Univ. Hospital of Tokushima
Awards:
The JapaneseSociety of Social Psychiatry (JSSP)/World Association for Social Psychiatry (WASP) Award at the XVIII World Congress of World Association for Social Psychiatry (Oct., 2004)
Outstanding Intellectuals of the 21st Century from International Biographical Centre (IBC, Dec., 2003)
21st Century Award for Achievement from International Biographical Centre (IBC, May, 2003)
Lilly Fellowship Award from the Japanese Society of Clinical Neuropsychopharmacology (JSCNP; Oct., 2001)
The European Certificate Award from the World Federation of Societies of Biological Psychiatry (WFSBP; July, 2000)
The Award of the Tokushima Medical Association (Jan., 2000)
Grants:
Daido Life Welfare Foundation (2009)
Japanese Association of Neuro-Psychiatric Clinics (Ken TANAKA Memorial Grant, 2008)
Reseach Group for Schizophrenia (2005, 2006)
The Health Care Science Institute (2005)
Pharmacopsychiatry Research Foundation (2001-2004)
Japan-North America Medical Exchange Foundation (JANAMEF; 2003)
Pfizer Health Research Foundation (2003)
Reviewing for the following Journals:
Biological Psychiatry (2007, 2008)
European Archives of Psychiatry and Clinical Neuroscience (2005)
Expert Opinion in Pharmacotherapy (2002)
International Journal of Neuropsychopharmacology (2004)
International Journal of Psychiatry in Clinical Practice (2008)
Journal of Clinical Psychopharmacology (2007, 2008)
Journal of Psychiatry & Neuroscience (2003)
Journal of Psychopharmacology (2005)
Open Neuroendocrinology Journal (2009)
Progress in Neuro-Psychopharmacology & Biological Psychiatry. (2004, 2006)
Psychiatry & Clinical Neurosciences (2001, 2002, 2004- 2009)
Psychiatry Research (2002-2004, 2007)
Psyoneuroendocrinology (2006, 2008)
Schizophrenia Research (2008, 2009)
My biography appears in:
Who's Who in Medicine & HealthCare (4th-6th Ed, 2009-2010)
Who's Who in the World (18th-24th Ed)
Who's Who in Science & Engineering (6th-9th Ed)
Who's Who in Finance & Industry (32nd and 33rd Ed)
Who's Who in America (58th Ed)
Who's Who in Asia (1st Ed)
2000 Outstanding Scientists of the 21st Century
2000 Outstanding Intellectuals of the 21st Century
Membership in medical societies:
American Psychiatric Association
Collegium Internationale Neuro-Psychopharmacologium
German Society for Biological Psychiatry
International Brain Research Organization
International Neuropsychiatric Association
International Psychogeriatric Association
International Society of Psychoneuroendocrinology
Japan Psychogeriatric Society
Japanese Society of Biological Psychiatry
Japanese Society of Clinical Neuropsychopharmacology
Japanese Society of Neuropsychopharmacology
Japanese Society for Psychiatric Diagnosis
Japanese Society of Psychiatry & Neurology
Japanese Society of Psychosomatic Medicine
Japanese Society of Mood Disorders
Society of Biological Psychiatry
Important publications
Kaneda Y, Sumiyoshi T, Keefe R, Ishimoto Y, Numata S, Ohmori T Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci. 2007 Dec;61(6):602-9. Abstract
Tomotake M, Kaneda Y, Iga J, Kinouchi S, Tayoshi S, Motoki I, Sumitani S, Yamauchi K, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T Subjective and objective measures of quality of life have different predictors for people with schizophrenia. Psychol Rep. 2006 Oct;99(2):477-87. Abstract
Taniguchi T, Sumitani S, Aono M, Iga J, Kinouchi S, Aki H, Matsushita M, Taniguchi K, Tsuno M, Yamanishi K, Tomotake M, Kaneda Y, Ohmori T Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms. Hum Psychopharmacol. 2006 Oct;21(7):439-45. Abstract
Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett. 2006 Jun 19;401(1-2):1-5. Epub 2006 Mar 14. Abstract
Kaneda Y, Kawamura I, Ohmori T Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia. Clin Neuropharmacol. 2005 Nov-Dec;28(6):262-4. Abstract
Kaneda Y Suicidality in schizophrenia as a separate symptom domain that may be independent of depression or psychosis. Schizophr Res. 2006 Jan 1;81(1):113-4. Epub 2005 Nov 16.
Kaneda Y, Ohmori T Relation between estradiol and negative symptoms in men with schizophrenia. J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):239-42. Abstract
Kaneda Y, Kawamura I, Fujii A, Ohmori T Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia. Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):135-40. Abstract
Meltzer HY, Li Z, Kaneda Y, Ichikawa J Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. Abstract
Kaneda Y, Ohmori T Impact of risperidone medication on quality of life and gonadal axis hormones in schizophrenia male patients with acute exacerbation. Int J Neuropsychopharmacol. 2003 Sep;6(3):247-52. Abstract
Kaneda Y, Kawamura I, Fujii A, Ohmori T Repetitive behaviors in chronic schizophrenia: using the Japanese version of the Elgin Behavior Rating Scale (JEBRS). Int J Neurosci. 2003 Jun;113(6):879-90. Abstract
Kaneda Y, Fujii A No relationship between testosterone levels and depressive symptoms in aging men. Eur Psychiatry. 2002 Nov;17(7):411-3. Abstract
Kaneda Y, Imakura A, Fujii A, Ohmori T Schizophrenia Quality of Life Scale: validation of the Japanese version. Psychiatry Res. 2002 Dec 15;113(1-2):107-13. Abstract
Kaneda Y, Fujii A, Ohmori T The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jun;26(5):935-8. Abstract
Kaneda Y, Kawamura I, Fujii A, Ohmori T Serotonin syndrome - ’potential’ role of the CYP2D6 genetic polymorphism in Asians. Int J Neuropsychopharmacol. 2002 Mar;5(1):105-6.
Kaneda Y, Fujii A Gynecomastia with sulpiride. J Clin Pharm Ther. 2002 Feb;27(1):75-7. Abstract
Kaneda Y Successful treatment with trazodone for repetitive behavior in schizophrenia. Nord J Psychiatry. 2001;55(6):448.
Kaneda Y, Ohmori T, Okabe H Possible mild serotonin syndrome related to co-prescription of tandospirone and trazodone. Gen Hosp Psychiatry. 2001 Mar-Apr;23(2):98-101.
Kaneda Y, Morimoto T, Fujii A Gynecomastia induced by treatment with tandospirone, a 5-HT1A agonist. J Psychiatry Neurosci. 2001 Mar;26(2):152-3.
Kaneda Y, Fujii A, Ohmori T Psychometric properties of the Japanese version of the Calgary Depression Scale for Schizophrenics. J Nerv Ment Dis. 2000 Apr;188(4):237-9.